DADATA·ANALYSIS
FREE
company · cik 2104204

Alamar Biosciences, Inc.

ALMRNasdaqSIC 3826public
financials · annual · usd2026
Revenue$13.1M
Net income-$7.7M
Total assets$140.0M
Total liabilities$64.0M
Equity-$159.0M
Operating cash-$13.1M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts3